Pacira Pharmaceuticals reported $146.18M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acelrx Pharmaceuticals ACRX:US USD 7.14M 7M
Aerie Pharmaceuticals AERI:US USD 62.8M 11.35M
Amerisourcebergen ABC:US USD 60.72B 1.2B
Astellas Pharma 4503:JP JPY 293.65B 54.99B
Bristol Myers Squibb BMY:US USD 8.75B 552M
Cara Therapeutics CARA:US USD 34.66M 7.18M
Coherus Biosciences CHRS:US USD 125.87M 21.71M
Depomed DEPO:US USD 27.78M 3.44M
Endo International Ordinary Shares ENDP:US USD 1.18B 1.13B
Heron Therapeutics HRTX:US USD 68.44M 8.69M
Horizon Pharma HZNP:US USD 764.75M 23.1M
Ironwood Pharmaceuticals IRWD:US USD 40.16M 1.41M
Johnson & Johnson JNJ:US USD 17.97B 211M
Lannett LCI:US USD 88.11M 64.04M
Ligand Pharmaceuticals LGND:US USD 65.45M 9.36M
Nektar Therapeutics NKTR:US USD 77.93M 96.49M
Omeros OMER:US USD 50.77M 13.33M
Pacira Pharmaceuticals PCRX:US USD 146.18M 8M
Perrigo Ordinary Shares PRGO:US USD 1.07B 71.2M
Pfizer PFE:US USD 13.23B 2.41B
Revance Therapeutics RVNC:US USD 106.5M 20.29M
Supernus Pharmaceuticals SUPN:US USD 178.88M 20.17M
Teva Pharmaceutical TEVA:IT USD 3.18B 1.56B
Xeris Pharmaceuticals Inc XERS:US USD 48.5M 4.28M
Xoma XOMA:US USD 4.82M 927K
Zoetis ZTS:US USD 1.34B 47M